Abstract
Plasmonic biosensors are increasingly being used for the analysis of extracellular vesicles (EVs) originating from disease areas. However, the high non-specific binding of EVs to a gold-sensing surface has been a critical problem and hindered the true translational potential. Here, we report that direct antibody immobilization on the plasmonic gold surface via physisorption shows excellent capture of cancer-derived EVs with ultralow non-specific binding even at very high concentrations. Contrary to commonly used methods that involve thiol-based linker attachment and an EDC/sulfo-NHS reaction, we show a higher specific capture rate and >50-fold lower non-specific on citrate-capped plain and nanopatterned gold surfaces. The method provides a simple, fast, and reproducible means to functionalize plasmonic gold surfaces with antibodies for robust EV biosensing.
Funding Information
  • National Cancer Institute (R21CA217662)
  • Korea Health Industry Development Institute (HI21C0957)
  • National Research Foundation of Korea (NRF-2021R1A6A3A14039686)
  • Ministry of Trade, Industry and Energy (20008829)
  • National Institute of General Medical Sciences (R01GM138778)

This publication has 56 references indexed in Scilit: